Lista de obras - Connie Fernández-Cid Marras

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

artículo científico publicado en 2017

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

artículo científico publicado en 2008

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts

artículo científico

Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker

artículo científico

Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer

artículo científico publicado en 2017

Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses

artículo científico publicado en 2014

Anti-inflammatory drug use and progressive supranuclear palsy

artículo científico publicado en 2017

Antipsychotic Use and Physical Morbidity in Parkinson Disease

artículo científico publicado en 2017

Antipsychotic use in older adults with Parkinson's disease

artículo científico publicado en 2007

Antipsychotics and mortality in Parkinsonism

artículo científico publicado en 2012

Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study

artículo científico publicado en 2016

Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease

artículo científico publicado en 2016

Atypical Antipsychotics Have Very Different Adverse Effect Profiles and Should Not Be Lumped Together—Reply

Atypical Antipsychotics and Parkinsonism

artículo científico publicado en 2005

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

artículo científico publicado en 2005

Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.

artículo científico publicado en 2012

Author reply to Holford, Vu and Nutt regarding ‘piecing together the puzzle of progression and mortality in Parkinson's disease’ ⬇️

artículo científico publicado el 1 de mayo de 2013

Barriers and facilitators of communication about off periods in Parkinson's disease: Qualitative analysis of patient, carepartner, and physician Interviews

scholarly article by Melissa J Armstrong et al published 2019 in PLOS ONE

Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort Study

artículo científico publicado en 2020

Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers

artículo científico publicado en 2016

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

artículo científico publicado en 2015

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

artículo científico

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study

artículo científico publicado en 2018

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

artículo científico publicado en 2018

Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease

artículo científico publicado en 2015

Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.

artículo científico publicado en 2011

Confounders and intermediaries in case-control study designs: a strategy for distinguishing between the two when measured using the same variable

artículo científico publicado en 2010

Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada

artículo científico publicado en 2014

Dietary fat intake, pesticide use, and Parkinson's disease

scientific article published on October 2013

Dihydropyridine calcium channel blockers and the progression of parkinsonism

artículo científico publicado en 2012

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease

scholarly article by Sean J Udow et al published 27 November 2017 in Movement disorders clinical practice

Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

artículo científico publicado en 2018

Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study

artículo científico publicado en 2016

Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples

artículo científico publicado en 2012

Genetic modification of the association of paraquat and Parkinson's disease

artículo científico publicado en 2012

Genetics meets environment: evaluating gene-environment interactions in neurologic diseases

artículo científico publicado en 2011

Genotype-phenotype relations for the Parkinson's Disease genes Parkin, PINK1, DJ1: MDSGene Systematic Review

artículo científico publicado en 2018

Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review

article

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

artículo científico publicado en 2017

Head injury, α-synuclein Rep1, and Parkinson's disease

artículo científico publicado en 2012

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease

artículo científico publicado en 2017

Helicobacter pylori infection is associated with worse severity of Parkinson's disease

artículo científico publicado en 2014

Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease

artículo científico publicado en 2013

Improvement of apathy after levofloxacin treatment: an N-of-1 study

artículo científico publicado en 2012

Independent application of montreal cognitive assessment/mini-mental state examination conversion

artículo científico publicado en 2015

Inflammatory profile in LRRK2-associated prodromal and clinical PD

artículo científico publicado en 2016

Initiating dopaminergic treatment in Parkinson's disease

artículo científico publicado en 2014

Investigation of c9orf72 in 4 neurodegenerative disorders

artículo científico publicado en 2012

Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain

artículo científico publicado en 2008

Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease? ⬇️

artículo científico publicado el 10 de noviembre de 2012

Is there seasonal variation in risk of Parkinson's disease?

artículo científico publicado en 2007

Knowledge of Parkinson's Disease in a Multiethnic Urban Asian Setting

artículo científico publicado en 2015

Launching the movement disorders society genetic mutation database (MDSGene).

artículo científico publicado en 2016

Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study

artículo científico publicado en 2018

Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications

artículo científico publicado en 2015

Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy

artículo científico publicado en 2013

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease

scholarly article by Christine Klein et al published 2018 in Journal of Parkinson's disease

Management of neuropsychiatric symptoms in long-term care residents with Parkinson's disease: a retrospective cohort study

artículo científico publicado en 2013

Measuring mild cognitive impairment in patients with Parkinson's disease

artículo científico publicado en 2013

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

artículo científico publicado en 2014

Mild cognitive impairment as a risk factor for Parkinson's disease dementia

artículo científico publicado en 2017

Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

artículo científico publicado en 2016

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease

artículo científico publicado en 2017

New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice

artículo científico publicado en 2005

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force

artículo científico publicado en 2017

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

artículo científico publicado en 2016

Nonmotor Signs in Genetic Forms of Parkinson's Disease

artículo científico

Nonmotor features of Parkinson's disease subtypes

artículo científico publicado en 2016

Occupation and risk of parkinsonism: a multicenter case-control study

artículo científico publicado en 2009

Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomings

artículo científico publicado en 2004

Parkinson's disease subtypes: lost in translation?

artículo científico

Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.

artículo científico publicado en 2017

Peptidoglycan recognition protein genes and risk of Parkinson's disease

artículo científico publicado en 2014

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

artículo científico publicado en 2008

Piecing together the puzzle of progression and mortality in Parkinson's disease ⬇️

artículo científico publicado el 1 de agosto de 2012

Pimozide for tics in Tourette syndrome

artículo científico publicado en 2008

Pimozide for tics in Tourette's syndrome

artículo científico publicado en 2009

Predicting motor decline and disability in Parkinson disease: a systematic review

artículo científico publicado en 2002

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial

artículo científico publicado en 2008

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts

artículo científico

Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease

artículo científico publicado en 2015

Protocol for a systematic review of prognosis after mild traumatic brain injury: an update of the WHO Collaborating Centre Task Force findings

artículo científico publicado en 2012

Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations

artículo científico publicado en 2004

Re: Cabergoline versus levodopa monotherapy: a decision analysis

artículo científico publicado en 2004

Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data

artículo científico publicado en 2016

Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!

artículo científico publicado en 2016

Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials

scholarly article by Alberto J. Espay et al published 13 April 2011 in Movement Disorders

Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect

artículo científico publicado en 2018

Risk factors for non-motor symptoms in Parkinson's disease

artículo científico publicado en 2018

Rotenone, paraquat, and Parkinson's disease

artículo científico publicado en 2011

Sequence of electrode implantation and outcome of deep brain stimulation for Parkinson's disease

artículo científico publicado en 2015

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease

scholarly article by Rezzak Yilmaz et al published 2018 in Frontiers in Neurology

Small intestinal bacterial overgrowth in Parkinson's disease

artículo científico publicado en 2014

Smell identification ability in twin pairs discordant for Parkinson's disease

artículo científico publicado en 2005

Solvent exposures and Parkinson disease risk in twins

artículo científico publicado en 2012

Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better

artículo científico

Subtypes of Parkinson's disease: state of the field and future directions

artículo científico

Systematic review of the risk of dementia and chronic cognitive impairment after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

artículo científico

Telemedicine in Parkinson's disease: A patient perspective at a tertiary care centre

artículo científico publicado en 2015

The Danger of Not Treating Parkinson Disease Psychosis-Reply

artículo científico publicado en 2016

The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: phenotype in monozygotic twins

artículo científico publicado en 2008

The complexities of hormonal influences and risk of Parkinson's disease

artículo científico publicado en 2014

The curious case of phenocopies in families with genetic Parkinson's disease

artículo científico publicado en 2011

The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease

artículo científico publicado en 2012

The pill questionnaire in a nondemented Parkinson's disease population

artículo científico publicado en 2012

The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies

artículo científico publicado en 2017

The relevance of pre-motor symptoms in Parkinson's disease

artículo científico

The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease

artículo científico publicado en 2014

Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtable

artículo científico publicado en 2014

Treatable inherited rare movement disorders

artículo científico publicado en 2017

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

artículo científico publicado en 2018

Understanding falls in progressive supranuclear palsy

artículo científico publicado en 2016

Urate as a predictor of the rate of clinical decline in Parkinson disease

artículo científico publicado en 2009

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease

artículo científico publicado en 2016

Lista de obras de Connie Fernández-Cid Marras

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts

Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker

Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer

Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses

Anti-inflammatory drug use and progressive supranuclear palsy

Antipsychotic Use and Physical Morbidity in Parkinson Disease

Antipsychotic use in older adults with Parkinson's disease

Antipsychotics and mortality in Parkinsonism

Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study

Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease

Atypical Antipsychotics Have Very Different Adverse Effect Profiles and Should Not Be Lumped Together—Reply

Atypical Antipsychotics and Parkinsonism

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.

Author reply to Holford, Vu and Nutt regarding ‘piecing together the puzzle of progression and mortality in Parkinson's disease’ ⬇️

Barriers and facilitators of communication about off periods in Parkinson's disease: Qualitative analysis of patient, carepartner, and physician Interviews

Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort Study

Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease

Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.

Confounders and intermediaries in case-control study designs: a strategy for distinguishing between the two when measured using the same variable

Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada

Dietary fat intake, pesticide use, and Parkinson's disease

Dihydropyridine calcium channel blockers and the progression of parkinsonism

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease

Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study

Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples

Genetic modification of the association of paraquat and Parkinson's disease

Genetics meets environment: evaluating gene-environment interactions in neurologic diseases

Genotype-phenotype relations for the Parkinson's Disease genes Parkin, PINK1, DJ1: MDSGene Systematic Review

Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

Head injury, α-synuclein Rep1, and Parkinson's disease

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease

Helicobacter pylori infection is associated with worse severity of Parkinson's disease

Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease

Improvement of apathy after levofloxacin treatment: an N-of-1 study

Independent application of montreal cognitive assessment/mini-mental state examination conversion

Inflammatory profile in LRRK2-associated prodromal and clinical PD

Initiating dopaminergic treatment in Parkinson's disease

Investigation of c9orf72 in 4 neurodegenerative disorders

Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain

Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease? ⬇️

Is there seasonal variation in risk of Parkinson's disease?

Knowledge of Parkinson's Disease in a Multiethnic Urban Asian Setting

Launching the movement disorders society genetic mutation database (MDSGene).

Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study

Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications

Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease

Management of neuropsychiatric symptoms in long-term care residents with Parkinson's disease: a retrospective cohort study

Measuring mild cognitive impairment in patients with Parkinson's disease

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

Mild cognitive impairment as a risk factor for Parkinson's disease dementia

Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease

New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

Nonmotor Signs in Genetic Forms of Parkinson's Disease

Nonmotor features of Parkinson's disease subtypes

Occupation and risk of parkinsonism: a multicenter case-control study

Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomings

Parkinson's disease subtypes: lost in translation?

Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.

Peptidoglycan recognition protein genes and risk of Parkinson's disease

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Piecing together the puzzle of progression and mortality in Parkinson's disease ⬇️

Pimozide for tics in Tourette syndrome

Pimozide for tics in Tourette's syndrome

Predicting motor decline and disability in Parkinson disease: a systematic review